It won't tell you your blood glucose level
In the long human effort to make invisible illness visible through technology, Huawei has announced a feature for its Watch 4 that promises to warn wearers of dangerous blood sugar spikes — not by measuring glucose, but by reading the body's surrounding signals. It is a meaningful distinction: the difference between a smoke detector and a fire, between inference and knowledge. Without transparency about how the system works or how reliable it is, the announcement asks us to trust a claim that medicine, and the people living with diabetes, cannot yet verify.
- Huawei is marketing a glucose risk feature that doesn't actually measure glucose — it infers danger from 10 indirect health metrics, a gap the company has not fully explained.
- For diabetics, the stakes are not abstract: hyperglycemia and hypoglycemia can become life-threatening if warning signs are missed or misread by an unvalidated algorithm.
- The company has released no methodology or accuracy data, leaving clinicians and patients with no way to calibrate how seriously to take the watch's alerts.
- Apple has been chasing true non-invasive glucose monitoring for years without success, underscoring just how technically difficult the problem Huawei claims to have partially solved actually is.
- The Watch 4 is unlikely to reach U.S. consumers, meaning the announcement may matter more as a signal of where wearable health tech is heading than as an immediate product reality.
Huawei has announced that its new Watch 4 can detect signs of dangerously high blood sugar in as little as 60 seconds — a headline that demands a closer read. The watch does not measure blood glucose. Instead, it analyzes 10 health metrics, among them heart rate and pulse wave data, to infer whether a spike might be occurring. If the algorithm flags risk, it sends a warning. It is a proxy system, not a diagnostic one.
This distinction carries real weight. For years, Apple has been rumored to be on the verge of true non-invasive glucose monitoring — whispers that followed the Watch 7, the Watch 8, and the Watch 9 without ever materializing. The science is genuinely hard. Huawei's approach sidesteps the core challenge entirely by never attempting direct measurement at all.
What the company has built is closer to an early warning system, drawing on hardware already present in the watch — blood pressure, blood oxygen, body temperature sensors — to flag potential hyperglycemia. Huawei has been vague about the full methodology and has not released validation data. For people managing diabetes, that opacity is not a minor inconvenience. Both hyperglycemia and hypoglycemia can become life-threatening, and a patient who substitutes this feature for a fingerstick test or continuous glucose monitor could miss a dangerous swing entirely.
Huawei has not positioned the feature as a replacement for standard monitoring, only as a supplementary safeguard. But without published accuracy data, there is no way to know how much the warnings should be trusted. The watch is also unlikely to reach the U.S. market. For now, the announcement is less a product than a signpost — a reminder that in health technology, the most important question is often not what a device claims to do, but precisely what it does not.
Huawei has announced a glucose monitoring feature for its new Watch 4, a claim that sounds revolutionary until you learn what it actually does. The company says the watch can detect signs of dangerously high blood sugar in as little as 60 seconds—but it won't tell you your blood glucose level. Instead, it measures 10 different health metrics, including heart rate and pulse wave characteristics, to infer whether your blood sugar might be spiking. If the algorithm detects risk, it sends you a warning.
This distinction matters enormously. For years, rumors have circulated that Apple was close to putting true non-invasive glucose monitoring on the Apple Watch. Those whispers date back to at least the Watch 7, then the Watch 8, then the Watch 9. None of it materialized. The technology is genuinely difficult to miniaturize and validate. Huawei's approach sidesteps the hardest part of the problem: it doesn't measure glucose at all.
What Huawei has built is more like an early warning system. The watch already contains hardware to track blood pressure, blood oxygen, and body temperature. The company is using these measurements, along with heart rate data and other metrics it hasn't fully disclosed, to flag potential hyperglycemia. It's a proxy, not a direct measurement. The company has been vague about how the system works and hasn't released validation data showing how accurate it actually is.
For people managing diabetes, this distinction is not academic. Hyperglycemia and hypoglycemia are serious conditions that can become life-threatening. A diabetic who relies on this watch feature instead of traditional blood glucose monitoring—a fingerstick test or a continuous glucose monitor—could miss dangerous swings in their blood sugar. Huawei itself hasn't positioned this as a replacement for standard monitoring, but as a supplementary safeguard. The problem is that without transparency about methodology and accuracy, it's impossible to know how much weight to give the warnings.
The feature will likely remain theoretical for most readers. Huawei products rarely reach the U.S. market, and there's no indication this watch will be an exception. Apple, meanwhile, continues working on actual non-invasive glucose tracking—technology that would measure blood sugar directly rather than inferring it from other vital signs. When or if that arrives remains unclear. The company has been burned by overpromising on health features before, and executives have acknowledged that fitting this kind of sensor into a watch is genuinely hard.
For now, Huawei's announcement represents a small step forward in the long march toward wearable glucose monitoring, even if the step is smaller than the headline suggests. It's a reminder that sometimes the most important part of a health claim is understanding exactly what's being claimed—and what isn't.
Citas Notables
Hyper and hypoglycemia are serious issues for diabetics, and can be life threatening, so they're not the kind of thing you want to leave to chance.— Tom's Guide analysis
La Conversación del Hearth Otra perspectiva de la historia
So Huawei is measuring blood sugar on the Watch 4. That's the headline, right?
That's what people will read, but it's not quite accurate. The watch measures 10 other things—heart rate, pulse patterns, things like that—and uses those to guess whether your blood sugar might be high. It's not measuring glucose directly.
Why would they do it that way instead of measuring glucose?
Because measuring glucose non-invasively through the skin is extremely hard. Apple's been trying for years. Huawei found a workaround: use the signals your body already gives off when blood sugar rises and try to catch the pattern.
Does it work?
We don't know. Huawei hasn't released any data on accuracy. They haven't even fully explained which metrics they're using or how they're weighted. For a diabetic, that's a problem.
Why is it a problem if it's just a warning system?
Because hyperglycemia can be dangerous fast. If someone trusts this watch instead of checking their actual blood sugar, they could miss something critical. It's supposed to be a backup, but without knowing how reliable it is, you can't really trust it as anything.
Will Americans be able to use it?
Almost certainly not. Huawei products don't typically sell in the U.S., and there's no sign this will be different. Apple's still working on the real thing, but they've been saying that for years too.